Laboratoires Euromedis specializes in the design, manufacturing and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The products include gloves (No. 1 in France in disposable medical gloves), surgical items (sensors, pockets, scalpels, etc.), hygiene and protection equipment (white-coats, masks, shoes, etc.), parenteral approaches (needles, syringes, transfusion equipment, etc.), diagnostic products, etc.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	14.85M 16.9M 13.68M 12.79M 23.99M 1.59B 24.43M 164M 63.57M 786M 63.48M 62.09M 2.73B	P/E 2024	-2.05x	P/E 2025	-84.9x
Enterprise Value	4.28M 4.88M 3.95M 3.69M 6.92M 460M 7.05M 47.34M 18.34M 227M 18.31M 17.91M 788M	EV / Sales 2024	0.57x	EV / Sales 2025	0.01x
Free-Float	34.87%	Yield 2024 *	-	Yield 2025	-

04-30	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/11/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
05/05/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/10/24	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
31/10/23	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/09/22	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2022	CI
29/04/22	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2021	CI
30/09/21	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2021	CI
08/07/21	Euromedis Groupe : Malaysia rubber glove body pleads for go-ahead to restart factories	RE
26/04/21	Global markets live: Philips, Crédit Suisse, Nestlé...
23/04/21	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2020	CI
24/09/20	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2020	CI

31/10/25	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER SEMESTRIEL 2025	PU
31/10/25	Laboratoires Euromedis : Euromedis - Communiqué semestriel 2025	PU
10/12/24	LABORATOIRES EUROMEDIS : Ajustement du contrat de liquidité	PU
26/04/24	Laboratoires Euromedis : Euromedis - Communiqué résultat 2023	PU
30/09/22	EUROMEDIS : Rapport Financier semestriel 2022	PU

06-19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
05-06	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER ANNUEL 2025
05-06	LABORATOIRES EUROMEDIS : Fin du contrat de liquidité
04-24	Laboratoires Euromedis : Communiqué résultat 2025
04-24	Laboratoires Euromedis : Résultats 2025 (7. Laboratoires Euromedis Communiqu e de presse r sultat 2025 v23.04.26)

Director	Title	Age	Since
Mathieu Roturier CHM	Chairman	49	26/11/2019
Francky Défossé BRD	Director/Board Member	39	-
Joseph Asselin BRD	Director/Board Member	52	08/03/2017

EUROMEDIS Stock Swiss Exchange

Stocks

OXEUMD

FR0000075343

Medical Equipment, Supplies & Distribution

Valuation: EUROMEDIS

Latest news : EUROMEDIS

Press Releases: EUROMEDIS

News in other languages: EUROMEDIS

Managers and Directors: EUROMEDIS

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EUROMEDIS	-.--%	-.--%	-	-	16.9M
ABBOTT LABORATORIES	+3.04%	+5.46%	-32.14%	-13.71%	162B
MEDTRONIC PLC	+0.49%	+1.49%	-6.34%	-7.96%	103B
CENCORA, INC.	+0.87%	+5.56%	-1.84%	+52.90%	55.83B
HOYA CORPORATION	-2.09%	-6.13%	+51.65%	+53.01%	54.05B
BECTON, DICKINSON AND COMPANY	+2.44%	+5.14%	-11.42%	-40.99%	41.71B
MEDLINE INC.	+4.77%	+5.09%	-	-	31.94B
DEXCOM, INC.	-1.58%	-5.27%	-18.93%	-45.84%	26.49B
WEST PHARMACEUTICAL SERVICES, INC.	+1.81%	+5.67%	+56.80%	-5.57%	24.48B
STERIS PLC	+1.66%	+3.94%	-12.39%	-0.10%	20.52B
Average	+0.34%	+1.70%	+3.17%	-1.03%	57.83B
Weighted average by Cap.	+0.25%	+2.27%	-6.19%	-0.59%

	2024	2025
Net sales	36.41M 41.45M 33.55M 31.37M 58.83M 3.91B 59.91M 403M 156M 1.93B 156M 152M 6.7B	41.06M 46.75M 37.83M 35.37M 66.35M 4.41B 67.56M 454M 176M 2.17B 176M 172M 7.56B
Net income	-6.11M -6.95M -5.63M -5.26M -9.87M -656M -10.05M -67.52M -26.15M -323M -26.11M -25.54M -1.12B	-132K -150K -121K -114K -213K -14.16M -217K -1.46M -564K -6.98M -563K -551K -24.25M
Net Debt	8.04M 9.15M 7.4M 6.92M 12.99M 863M 13.22M 88.84M 34.41M 426M 34.36M 33.61M 1.48B	-10.57M -12.03M -9.73M -9.1M -17.07M -1.13B -17.38M -117M -45.24M -559M -45.17M -44.18M -1.94B